Basic & Clinical Medicine ›› 2010, Vol. 30 ›› Issue (7): 698-702.
• 研究论文 • Previous Articles Next Articles
Chun-yan LIU, Chang-lin MEI, Li YUAN, Yi ZHANG, Li-li FU, Hou-an CAI, Xue-qi WANG
Received:
Revised:
Online:
Published:
Contact:
Abstract: Objective To investigate antiproliferative effect and reduction of VEGF expression of rapamycin on ADPKD cystic lining epithelial cells. Methods ADPKD cystic lining immortalized epithelial cells(WT9-12) were stimulated by rapamycin with different concentrations. After treatment, MTT method was performed to detect the levels of proliferation, the mRNA expressions of VEGF were measured by Real-time PCR. Western blot method was used to detect the protein expressions of cyclinD, P21, Bcl2, Bax and VEGF. Results Rapamycin , a mTOR inhibitor, was found to induce cell growth inhibition, apoptosis as well as a stable accumulation of cells in the G0/G1 phase. Western blot of cultured WT9-12 cells demonstrated that Rapamycin downregulated cyclinD, Bcl2 and upregulated p21, Bax expressions. In addition, realtime-PCR detected elevated levels of VEGF mRNA in primary cells from ADPKD patients and WT9-12 cells compared with normal tubule cells. Rapamycin downregulated VEGF expression in WT9-12 cells. Conclusion Rapamycin induces ADPKD cystic lining epithelial cells growth inhibition, apoptosis and inhibits VEGF expression, which may be one of mechanisms of rapamycin postponing ADPKD progression.
Key words: ADPKD, Rapamycin, Cell cycle, Apoptosis, VEGF
CLC Number:
R332.6
Chun-yan LIU; Chang-lin MEI; Li YUAN; Yi ZHANG; Li-li FU; Hou-an CAI; Xue-qi WANG. Antiproliferative and antiangiogenic effect of rapamycin on ADPKD cystic lining epithelial cells[J]. Basic & Clinical Medicine, 2010, 30(7): 698-702.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/
http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2010/V30/I7/698